TREATMENT OF MUCOUS MEMBRANE PEMPHIGOID WITH LOW-LEVEL LASER THERAPY

Abstract

Pemphigoid of the mucous membranes represents a group of subepithelial blistering diseases of autoimmune origin. The radiation emitted by the low-level laser affects the metabolic processes of the target cells, producing biostimulants that act in the process of regeneration of the tissues. A 34-year-old female patient presented clinically with an erythematous gingiva that was blistering and scaling, with painful and burning symptomatology. An excisional biopsy was performed, sent for histopathologic examination, confirming the diagnosis of mucous membrane pemphigoid. Treatment included low-level laser therapy at the wavelength 630 to 700 nm, following the 1 J protocol for interdental papilla, with an area of approximately 1 cm² per point, and use of steroids. The objective of this study is to demonstrate how laser therapy functions in the treatment of oral lesions of mucous membrane pemphigoid. Pemphigoid of the mucous membranes represents a group of subepithelial blistering diseases of autoimmune origin. The radiation emitted by the low-level laser affects the metabolic processes of the target cells, producing biostimulants that act in the process of regeneration of the tissues. A 34-year-old female patient presented clinically with an erythematous gingiva that was blistering and scaling, with painful and burning symptomatology. An excisional biopsy was performed, sent for histopathologic examination, confirming the diagnosis of mucous membrane pemphigoid. Treatment included low-level laser therapy at the wavelength 630 to 700 nm, following the 1 J protocol for interdental papilla, with an area of approximately 1 cm² per point, and use of steroids. The objective of this study is to demonstrate how laser therapy functions in the treatment of oral lesions of mucous membrane pemphigoid.